| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5045552 | AYTU | Pyridine derivatives having anti-ulcerative activity |
May, 2013
(10 years ago) | |
|
US5045552 (Pediatric) | AYTU | Pyridine derivatives having anti-ulcerative activity |
Nov, 2013
(10 years ago) | |
Aciphex Sprinkle is owned by Aytu.
Aciphex Sprinkle contains Rabeprazole Sodium.
Aciphex Sprinkle has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Aciphex Sprinkle are:
- US5045552
- US5045552*PED
Aciphex Sprinkle was authorised for market use on 26 March, 2013.
Aciphex Sprinkle is available in capsule, delayed release;oral dosage forms.
Aciphex Sprinkle can be used as treatment of peptic ulcers.
The generics of Aciphex Sprinkle are possible to be released after 26 September, 2016.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Pediatric Exclusivity(PED) | Sep 26, 2016 |
| New Dosage Form(NDF) | Mar 26, 2016 |
Drugs and Companies using RABEPRAZOLE SODIUM ingredient
Market Authorisation Date: 26 March, 2013
Treatment: Treatment of peptic ulcers
Dosage: CAPSULE, DELAYED RELEASE;ORAL
More Information on Dosage
ACIPHEX SPRINKLE family patents
